CN114469834A - Composition for inhibiting acne and preparation method and application thereof - Google Patents
Composition for inhibiting acne and preparation method and application thereof Download PDFInfo
- Publication number
- CN114469834A CN114469834A CN202111517687.2A CN202111517687A CN114469834A CN 114469834 A CN114469834 A CN 114469834A CN 202111517687 A CN202111517687 A CN 202111517687A CN 114469834 A CN114469834 A CN 114469834A
- Authority
- CN
- China
- Prior art keywords
- phase
- composition
- parts
- component
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 203
- 238000002360 preparation method Methods 0.000 title claims abstract description 49
- 230000002401 inhibitory effect Effects 0.000 title abstract description 38
- 206010000496 acne Diseases 0.000 title abstract description 34
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 31
- 239000002994 raw material Substances 0.000 claims abstract description 55
- 241000270708 Testudinidae Species 0.000 claims abstract description 34
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 31
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract description 28
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract description 28
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 27
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 23
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 23
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 20
- 241000405414 Rehmannia Species 0.000 claims abstract description 19
- 239000002537 cosmetic Substances 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 91
- 239000000284 extract Substances 0.000 claims description 64
- 238000001914 filtration Methods 0.000 claims description 54
- 238000010298 pulverizing process Methods 0.000 claims description 39
- 239000006071 cream Substances 0.000 claims description 35
- 238000002156 mixing Methods 0.000 claims description 33
- 238000010992 reflux Methods 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 18
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 18
- 241000213006 Angelica dahurica Species 0.000 claims description 16
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 13
- 235000011477 liquorice Nutrition 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 241000186427 Cutibacterium acnes Species 0.000 abstract description 34
- 229940055019 propionibacterium acne Drugs 0.000 abstract description 34
- 239000012528 membrane Substances 0.000 abstract description 19
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 10
- 229940010454 licorice Drugs 0.000 abstract description 10
- 239000004519 grease Substances 0.000 abstract description 9
- 230000028327 secretion Effects 0.000 abstract description 8
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 description 98
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 93
- 230000000052 comparative effect Effects 0.000 description 72
- 238000003756 stirring Methods 0.000 description 62
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 46
- 238000010438 heat treatment Methods 0.000 description 46
- 239000000706 filtrate Substances 0.000 description 38
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 34
- 229920002385 Sodium hyaluronate Polymers 0.000 description 32
- 229920002125 Sokalan® Polymers 0.000 description 32
- 229960001631 carbomer Drugs 0.000 description 32
- 235000011187 glycerol Nutrition 0.000 description 32
- 229940010747 sodium hyaluronate Drugs 0.000 description 32
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 32
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 31
- 229920001577 copolymer Polymers 0.000 description 31
- 239000008367 deionised water Substances 0.000 description 31
- 229910021641 deionized water Inorganic materials 0.000 description 31
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 30
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 30
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 30
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 30
- -1 polydimethylsiloxane Polymers 0.000 description 29
- 230000000694 effects Effects 0.000 description 28
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 28
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 26
- 235000019437 butane-1,3-diol Nutrition 0.000 description 23
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical group O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 22
- 239000004744 fabric Substances 0.000 description 22
- 230000005764 inhibitory process Effects 0.000 description 22
- 238000007873 sieving Methods 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 16
- 235000017491 Bambusa tulda Nutrition 0.000 description 16
- 241001330002 Bambuseae Species 0.000 description 16
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 16
- 239000011425 bamboo Substances 0.000 description 16
- 239000003610 charcoal Substances 0.000 description 16
- 238000004090 dissolution Methods 0.000 description 16
- 239000003205 fragrance Substances 0.000 description 16
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 14
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 14
- 244000125300 Argania sideroxylon Species 0.000 description 14
- 235000016108 Argania sideroxylon Nutrition 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 14
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 14
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 14
- 239000004205 dimethyl polysiloxane Substances 0.000 description 14
- 230000001804 emulsifying effect Effects 0.000 description 14
- 239000012467 final product Substances 0.000 description 14
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 14
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 14
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 14
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 14
- 229960003415 propylparaben Drugs 0.000 description 14
- 229940032094 squalane Drugs 0.000 description 14
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 14
- 108090001007 Interleukin-8 Proteins 0.000 description 11
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- 230000002757 inflammatory effect Effects 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 206010037888 Rash pustular Diseases 0.000 description 5
- 208000029561 pustule Diseases 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 235000015110 jellies Nutrition 0.000 description 4
- 239000008274 jelly Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- BBNQQADTFFCFGB-UHFFFAOYSA-N purpurin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC(O)=C3C(=O)C2=C1 BBNQQADTFFCFGB-UHFFFAOYSA-N 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 208000020154 Acnes Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 244000148064 Enicostema verticillatum Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000003797 telogen phase Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 241001404789 Smilax glabra Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010056717 Varicophlebitis Diseases 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 210000000887 face Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000027185 varicose disease Diseases 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 1
- ZROGCCBNZBKLEL-FHXNIQKESA-N Astilbin Natural products O([C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 ZROGCCBNZBKLEL-FHXNIQKESA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- ZROGCCBNZBKLEL-MPRHSVQHSA-N astilbin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1C(=O)C2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1 ZROGCCBNZBKLEL-MPRHSVQHSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229940072172 tetracycline antibiotic Drugs 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of cosmetics, and discloses a composition for inhibiting acne, a preparation method and application thereof. The composition comprises the following raw material components: tortoise plastron, glabrous greenbrier rhizome, rehmannia root, raw licorice, cape jasmine fruit and honeysuckle flower. Through the mutual synergistic effect of the tortoise plastron, the glabrous greenbrier rhizome, the rehmannia root, the raw liquoric root, the gardenia and the honeysuckle, the composition provided by the invention is nontoxic, can inhibit the reproduction of propionibacterium acnes, inhibit the release of outer membrane vesicles of propionibacterium acnes, inhibit the secretion of skin grease, inhibit the spread of acne and improve the influence of acne on the face, and has the characteristics of safe raw materials, simple preparation method and easy industrial realization.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a composition for inhibiting acne, and a preparation method and application thereof.
Background
Acne is a chronic inflammatory disease of pilosebaceous tissue, is caused by a large amount of androgen-induced sebum, abnormal keratinization of pilosebaceous glands, deposit of propionibacterium acnes, secondary inflammation and other reasons, and clinically shows various types of skin rash such as acne, nodules, pustules, papules, cysts and the like. Severe acne can lead to persistent scarring, skin damage, pustules, post-inflammatory pigmentation in the patient, and can have a serious negative impact on the quality of life, particularly the psychological aspects of the patient. Therefore, it is crucial to prevent and treat acne in a timely manner.
At present, various medicines are applied to the clinical treatment of acne, such as tetracycline, macrolide antibacterial medicines, benzoyl peroxide, vitamin A acid medicines, hormones and the like are common, and the medicines have slow effect and are easy to cause side effects after long-term use, such as teratogenicity and depression of isotretinoin, drug resistance improvement caused by erythromycin antibacterial medicines, vomiting and diarrhea caused by tetracycline antibiotics and the like.
Therefore, there is a need to provide a product that is safe and can inhibit acne.
Disclosure of Invention
The present invention is directed to solving at least one of the problems of the prior art described above. Therefore, the invention provides a composition for inhibiting acne, a preparation method and application thereof, which can effectively inhibit acne.
In a first aspect, the present invention provides a composition for inhibiting acne, the composition comprising the following raw material components: tortoise plastron, glabrous greenbrier rhizome, rehmannia root, raw liquoric root, cape jasmine fruit and honeysuckle flower.
In the pharmacological action, the tortoise plastron is salty and sweet in taste and cold in nature, enters kidney, liver and heart channels, can nourish yin and tonify kidney, is sufficient in kidney yin, clears heart fire, and has the effects of expelling toxin, nourishing yin and beautifying by taking the tortoise plastron as a monarch and the rhizoma smilacis glabrae as a minister. The rehmannia root, the liquorice, the gardenia and the honeysuckle have the effects of clearing heat and removing toxicity, the honeysuckle and the gardenia have the effect of clearing heat, the liquorice has the effect of removing toxicity, the rehmannia root has the effect of nourishing yin, and the rehmannia root is used for assisting the monarch and minister to nourish yin, clear heat and remove toxicity.
Rhizoma Smilacis Glabrae is sweet and light in flavor, neutral in nature, and enters liver and stomach meridians, and has effects of removing toxic substance, eliminating dampness, dispelling pathogenic wind and relieving pain. The record of the herbal atlas indicates that the glabrous greenbrier rhizome has the function of applying sore toxin, and has good curative effect on acne skin lesions and the glabrous greenbrier rhizome both for oral administration and external use. Modern pharmacological studies show that astilbin, the main component of smilax glabra, may affect the level of androgen in the body, thus affecting sebum secretion and affecting the living environment of propionibacterium acnes.
The dried rehmannia root is sweet and bitter in taste and cold in nature, enters heart, liver and kidney channels, and has the effects of clearing heat, cooling blood, nourishing yin and promoting the production of body fluid. The dried rehmannia root can inhibit vascular endothelial inflammation and experimental synovial swelling inflammation of joints of rats.
The liquorice has sweet taste and neutral nature, enters heart, lung, spleen and stomach channels, and has the effects of tonifying spleen and qi, clearing away heat and toxic materials, eliminating phlegm and stopping cough, relieving spasm and pain and harmonizing the medicines. In Zhongqing gan Cao from Yao Hua Yi (pharmaceutical science), raw licorice root, with the actions of cooling and purging fire, mainly dispersing exterior pathogen, resolving swollen welling-abscess, relieving sore throat, removing all drug-toxin, removing heat accumulated in stomach and relieving pain in ureter, also has the actions of cooling and removing heat. Modern researches have proved that glycyrrhizin, the main active ingredient of licorice, has the functions of detoxification and anti-inflammation, and licoflavone also has the anti-inflammation function, and is beneficial to repairing damaged skin.
Gardenia is bitter in taste and cold in nature, and enters heart channel, lung channel and triple energizer channel, and has the effects of purging pathogenic fire, relieving restlessness, clearing heat, promoting urination, cooling blood, removing toxicity, relieving swelling and pain by external use and inhibiting various pathogenic bacteria.
The honeysuckle flower is sweet in taste and cold in nature, enters lung, heart and stomach meridians, and has the effects of clearing away heat and toxic materials and dispelling wind and heat. The honeysuckle contains honeysuckle glycoside, tannin, alkaloid and the like, and the pharmacological test proves that the honeysuckle has the inhibiting effect on various pathogenic bacteria and has stronger carbuncle-dispersing, swelling-dispersing, heat-clearing, detoxifying and inflammation-diminishing effects on carbuncle, furuncle, acute appendicitis and pulmonary abscess.
According to some embodiments of the invention, the tortoise plastron is a ventral or dorsal concha of a tortoise.
According to some embodiments of the invention, the composition comprises the following raw material components in parts by weight: 1-20 parts of tortoise plastron, 1-25 parts of glabrous greenbrier rhizome, 1-20 parts of radix rehmanniae, 1-20 parts of raw liquorice, 1-15 parts of cape jasmine and 1-15 parts of honeysuckle.
Preferably, the composition comprises the following raw material components in parts by weight: 15-20 parts of tortoise plastron, 15-20 parts of glabrous greenbrier rhizome, 8-15 parts of radix rehmanniae, 15-20 parts of raw liquorice, 10-15 parts of cape jasmine and 10-15 parts of honeysuckle.
Preferably, the composition comprises the following raw material components in parts by weight: 16-20 parts of tortoise plastron, 16-20 parts of glabrous greenbrier rhizome, 10-14 parts of radix rehmanniae, 17-20 parts of raw liquorice, 11-14 parts of cape jasmine fruit and 13-15 parts of honeysuckle.
According to some embodiments of the invention, the composition further comprises the following raw material components: radix Angelicae Dahuricae.
The angelica dahurica is pungent in flavor and warm in nature, enters the channels of the lung, the spleen and the stomach, and has the effects of dispelling wind and cold, dredging orifices and relieving pain, reducing swelling and expelling pus, eliminating dampness and stopping leukorrhagia and the like. The compendium of materia medica says that the dahurian angelica root can be used as face fat, has the functions of relieving fever, easing pain, resisting inflammation, detoxifying and expelling pus and the like, and can improve local blood circulation and promote metabolism of the skin.
According to some embodiments of the invention, the composition comprises the following raw material components in parts by weight: 1-20 parts of tortoise plastron, 1-25 parts of glabrous greenbrier rhizome, 1-20 parts of radix rehmanniae, 1-20 parts of raw liquorice, 1-15 parts of cape jasmine fruit, 1-15 parts of honeysuckle and 1-10 parts of dahurian angelica root.
Preferably, the composition comprises the following raw material components in parts by weight: 15-20 parts of tortoise plastron, 15-20 parts of glabrous greenbrier rhizome, 8-15 parts of radix rehmanniae, 15-20 parts of raw liquorice, 10-15 parts of cape jasmine fruit, 10-15 parts of honeysuckle and 5-9 parts of dahurian angelica root.
Preferably, the composition comprises the following raw material components in parts by weight: 16-20 parts of tortoise plastron, 16-20 parts of glabrous greenbrier rhizome, 10-14 parts of radix rehmanniae, 17-20 parts of raw liquorice, 11-14 parts of cape jasmine fruit, 13-15 parts of honeysuckle and 6-8 parts of dahurian angelica root.
A second aspect of the present invention provides a process for the preparation of the above composition, said process comprising the steps of: obtaining extracts of the raw material components; mixing the extracts of the raw material components to obtain the composition.
According to some embodiments of the invention, the extract obtained from each raw material component is: pulverizing carapax et Plastrum Testudinis, decocting, filtering, and concentrating to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, extracting with solvent, and refluxing to obtain mixed extractive solution.
According to some embodiments of the invention, the solvent is at least one of water, methanol, ethanol; preferably, the solvent is a mixture of water and methanol or ethanol; preferably, the solvent is a mixture of water and ethanol; preferably, the solvent is ethanol water solution with the volume concentration of 60-70%.
According to some embodiments of the present invention, the extraction is microwave extraction, the frequency of the extraction is 2000-3000MHz, the power is 600-1000W, the temperature is 40-60 ℃, and the time is 20-60 min.
According to some embodiments of the invention, the method of preparing comprises the steps of:
(1) pulverizing carapax et Plastrum Testudinis, sieving with 100 mesh sieve, decocting with water for 2-5 times (each time for 0.5-3 hr), filtering the decoction, and vacuum concentrating in 60-90 deg.C water bath to obtain carapax et Plastrum Testudinis extract;
(2) pulverizing the rest raw materials, sieving with 100 mesh sieve, mixing, adding 60-70% ethanol solution, microwave extracting, and hot refluxing to obtain mixed extractive solution; the frequency of microwave extraction is 2000-3500MHz, and the power is 600-1000W; the extraction temperature is 35-45 deg.C, and the extraction time is 20-60 min; the reflux frequency is 3 times, and the reflux temperature is 70-90 ℃;
(3) mixing the carapax et Plastrum Testudinis extract and the mixed extractive solution, dissolving, filtering with 80-120 mesh filter cloth, vacuum concentrating the filtrate at 40-60 deg.C to 100g, and dissolving with 100g 1, 3-butanediol to obtain the composition.
A third aspect of the invention provides the use of a composition as described above in the preparation of a cosmetic product.
According to some embodiments of the invention, the composition is for use in the manufacture of a cosmetic product for inhibiting acne.
According to some embodiments of the invention, the composition is for use in the manufacture of a cosmetic for inhibiting the proliferation of propionibacterium acnes, inhibiting the release of outer membrane vesicles from propionibacterium acnes, and/or inhibiting the release of inflammatory factors.
In a fourth aspect, the present invention provides a cosmetic product comprising the composition described above.
According to some embodiments of the invention, the cosmetic is for inhibiting acne.
According to some embodiments of the invention, the cosmetic is for inhibiting the proliferation of propionibacterium acnes, inhibiting the release of outer membrane vesicles from propionibacterium acnes, and/or inhibiting the release of inflammatory factors.
According to some embodiments of the invention, the composition is added in an amount of 0.1% to 20% by weight of the total weight of the cosmetic product. Preferably, the composition is added in an amount of 0.1% to 10% by weight based on the total weight of the cosmetic.
According to some embodiments of the invention, the cosmetic is a gel, a cream, a mask, a lotion, a serum, or a lotion.
Therefore, the beneficial effects of the invention include:
1. the composition for inhibiting acne has no cytotoxicity by the mutual synergistic effect of tortoise plastron, glabrous greenbrier rhizome, rehmannia root, raw liquoric root, cape jasmine fruit and honeysuckle, and has the effects of inhibiting the reproduction of propionibacterium acnes, inhibiting the release of outer membrane vesicles of propionibacterium acnes and inhibiting the release of inflammatory factors;
2. the composition for inhibiting acne can inhibit the secretion of skin grease, improve mottle, wrinkles, textures, pores, purpura and red areas of the skin and reduce the white head, black head, pimple and cyst nodule of the face caused by the acne when being applied to the face.
3. The composition provided by the invention is safe in raw materials, simple in preparation method and easy to realize in industrialization.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions in the embodiments of the present invention are described clearly and completely below.
The technical scheme provided by the embodiment of the invention is described below.
Example 1
The present example provides a composition comprising the following raw material components: 16g of tortoise plastron, 20g of glabrous greenbrier rhizome, 14g of rehmannia root, 17g of raw liquorice, 12g of cape jasmine fruit, 13g of honeysuckle flower and 8g of dahurian angelica root.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, mixing, adding into 1.4L 70% ethanol water solution, performing microwave extraction at 3000MHz and 800W for 30min at 40 deg.C, extracting at 80 deg.C under reflux for 40min, and extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The embodiment also provides jelly which comprises a phase A component, a phase B component and a phase C component; the phase A component comprises 0.1 percent of disodium EDTA (namely disodium ethylene diamine tetraacetate), 0.1 percent of allantoin, 0.08 percent of sodium hyaluronate, 2 percent of glyceryl polyether-26, 1 percent of glycerin, 0.6 percent of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 percent of carbomer and 80.42 percent of water in percentage by weight; the phase B component comprises 4% of butanediol and 0.6% of p-hydroxyacetophenone; phase C component comprises 1% bamboo charcoal and 10% of the composition provided in this example.
The preparation method of the jelly comprises the following steps: heating and dissolving the B-phase component in a water bath kettle at 80 ℃ in advance until the component is transparent to obtain a B-phase mixture for later use; mixing the phase A components, heating and stirring in a water bath kettle at 80 ℃ until the components are dissolved uniformly, homogenizing for 3 minutes to ensure complete dissolution, and then cooling; cooling to 60 deg.C, adding the mixture of phase B, stirring to dissolve, and cooling; cooling to 45 deg.C, adding C phase component, and stirring; cooling to 37 deg.C, vacuumizing, defoaming, testing color, fragrance, pH, etc., filtering with 200 mesh sieve, and collecting the gel.
Example 2
The embodiment provides a composition for inhibiting acne, which comprises the following raw material components of 18g of tortoise plastron, 18g of glabrous greenbrier rhizome, 12g of radix rehmanniae, 20g of raw licorice, 14g of cape jasmine fruit, 12g of honeysuckle flower and 6g of dahurian angelica root.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting with 180g deionized water for 2 times (each time for 2 hr), mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 2L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 2000MHz and power of 1000W, extracting at 40 deg.C for 20min, extracting at 75 deg.C under reflux for 30min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated to 100g under vacuum at 60 ℃ and then 100g of 1, 3-butanediol was added to dissolve it uniformly to obtain the composition.
The embodiment also provides a face cream which comprises a phase a component, a phase b component, a phase c component and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer (namely acryloyl dimethyl taurate/VP copolymer) and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the d-phase component comprises 1% of bamboo charcoal and 5% of the composition provided by the embodiment.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, ammonium acryloyldimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b components in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the EDTA disodium, the sodium hyaluronate, the glycerol, the trehalose, the ammonium acryloyldimethyl taurate/vinyl pyrrolidone copolymer and the carbomer are dissolved uniformly, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying for 8 minutes at the speed of 5000rpm, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Example 3
The embodiment provides a composition for inhibiting acne, which comprises the following raw material components of 20g of tortoise plastron, 16g of rhizoma smilacis glabrae, 10g of radix rehmanniae, 19g of raw licorice, 14g of fructus gardeniae, 15g of honeysuckle and 6g of radix angelicae.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting with 400g deionized water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 60 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.6L ethanol water solution with volume ratio concentration of 80%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 600W, extracting at 45 deg.C for 25min, extracting at 70 deg.C under hot reflux for 30min, extracting for 4 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated to 100g under vacuum at 55 ℃ and 100g of 1, 3-butanediol was added to dissolve it uniformly to obtain the composition.
Example 4
The embodiment provides a composition, which comprises 16g of tortoise plastron, 20g of glabrous greenbrier rhizome, 14g of radix rehmanniae, 17g of raw licorice, 12g of cape jasmine fruit and 13g of honeysuckle flower.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting with 160g deionized water for 3 times, each time for 1 hr, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The embodiment also provides a face cream which comprises a phase a component, a phase b component, a phase c component and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the d-phase component comprises 1% of bamboo charcoal and 5% of the composition provided by the embodiment.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest phase C, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 1
This comparative example provides an extract comprising 100g of tortoise plastron as a raw material component. The preparation method of the extract comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting with 160g water for 3 times, each for 1 hr, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C to 100 g; adding 100g 1, 3-butanediol, and dissolving to obtain the extract.
Comparative example 2
The comparative example provides an extract comprising as raw material components 100g of glabrous greenbrier rhizome.
The preparation method of the extract comprises the following steps: pulverizing Poria, adding 1.4L 70% ethanol water solution, microwave extracting at frequency of 3000MHz and power of 800W for 30min at 40 deg.C, and hot refluxing at 80 deg.C for 40min for 3 times to obtain extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; vacuum concentrating at 50 deg.C to 100g, adding 100g 1, 3-butanediol, and dissolving to obtain the extract.
Comparative example 3
This comparative example provides an extract comprising raw material ingredients of 100g of rehmannia glutinosa libosch.
The preparation method of the extract comprises the following steps: pulverizing radix rehmanniae, adding 1.4L ethanol water solution with volume ratio concentration of 70%, microwave extracting at frequency of 3000MHz and power of 800W for 30min at 40 deg.C, and hot refluxing at 80 deg.C for 40min for 3 times to obtain extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; vacuum concentrating at 50 deg.C to 100g, adding 100g 1, 3-butanediol, and dissolving to obtain the extract.
Comparative example 4
The present comparative example provides an extract comprising 100g of raw licorice as a raw material component.
The preparation method of the extract comprises the following steps: pulverizing Glycyrrhrizae radix, adding 1.4L 70% ethanol water solution, microwave extracting at frequency of 3000MHz and power of 800W for 30min at 40 deg.C, and hot refluxing at 80 deg.C for 40min for 3 times to obtain extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; vacuum concentrating at 50 deg.C to 100g, adding 100g 1, 3-butanediol, and dissolving to obtain the extract.
Comparative example 5
The comparative example provides an extract comprising gardenia jasminoides ellis as a raw material component in an amount of 100 g.
The preparation method of the extract comprises the following steps: pulverizing fructus Gardeniae, adding 1.4L ethanol water solution with volume concentration of 70%, microwave extracting at frequency of 3000MHz and power of 800W for 30min at 40 deg.C, and heat refluxing at 80 deg.C for 40min for 3 times to obtain extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; vacuum concentrating at 50 deg.C to 100g, adding 100g 1, 3-butanediol, and dissolving to obtain the extract.
Comparative example 6
The comparative example provides an extract comprising 100g of honeysuckle as a raw material component.
The preparation method of the extract comprises the following steps: pulverizing flos Lonicerae, adding 1.4L ethanol water solution with volume ratio concentration of 70%, microwave extracting at frequency of 3000MHz and power of 800W for 30min at 40 deg.C, and hot refluxing at 80 deg.C for 40min for 3 times to obtain extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; vacuum concentrating at 50 deg.C to 100g, adding 100g 1, 3-butanediol, and dissolving to obtain the extract.
Comparative example 7
The comparative example provides an extract comprising 100g of radix angelicae as a raw material component.
The preparation method of the extract comprises the following steps: pulverizing radix Angelicae Dahuricae, adding 1.4L 70% ethanol water solution, microwave extracting at 3000MHz and 800W for 30min at 40 deg.C and 40min at 80 deg.C under reflux for 3 times to obtain extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; vacuum concentrating at 50 deg.C to 100g, adding 100g 1, 3-butanediol, and dissolving to obtain the extract.
Comparative example 8
The comparative example provides a composition comprising 16g of tortoise plastron and 20g of glabrous greenbrier rhizome as raw material components.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing Poria, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain extractive solution; dissolving carapax et Plastrum Testudinis extract in the extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the phase c component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying for 5-10 minutes at the speed of 5000rpm, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 9
The comparative example provides a composition comprising raw material components of 16g of tortoise plastron, 20g of glabrous greenbrier rhizome and 14g of rehmannia root.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the component of phase a comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadecanylsiloxane, 1 percent of polydimethylsiloxane, and 1 percent of hydrogenated lecithin; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerin, 0.5% of trehalose, 0.75% of acryloyl dimethyl ammonium taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 10
The comparative example provides a composition, which comprises the raw material components of 6g of tortoise plastron, 20g of glabrous greenbrier rhizome, 14g of rehmannia root, 12g of cape jasmine fruit and 13g of honeysuckle.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the phase c component into butanediol, and heating and dissolving in advance until the solution is transparent to obtain a phase c mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 11
The comparative example provides a composition comprising raw material components of 16g of tortoise plastron, 20g of glabrous greenbrier rhizome, 14g of radix rehmanniae and 17g of raw licorice.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, ammonium acryloyldimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b components in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the EDTA disodium, the sodium hyaluronate, the glycerol, the trehalose, the ammonium acryloyldimethyl taurate/vinyl pyrrolidone copolymer and the carbomer are dissolved uniformly, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 12
The comparative example provides a composition comprising the raw material components of 16g of tortoise plastron, 20g of glabrous greenbrier rhizome, 14g of rehmannia root and 8g of dahurian angelica root.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 13
The comparative example provides a composition comprising raw material components of 17g of raw licorice, 12g of gardenia and 13g of honeysuckle.
The preparation method of the composition comprises the following steps: pulverizing the components, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest phase C, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 14
The comparative example provides a composition, which comprises the raw material components of 12g of cape jasmine, 13g of honeysuckle and 8g of angelica dahurica.
The preparation method of the composition comprises the following steps: pulverizing the components, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the phase c component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 15
The comparative example provides a composition, which comprises 17g of raw licorice and 8g of angelica dahurica.
The preparation method of the composition comprises the following steps: pulverizing the components, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 16
The comparative example provides a composition, which comprises the raw material components of 17g of raw liquorice, 12g of cape jasmine, 13g of honeysuckle and 8g of angelica dahurica.
The preparation method of the composition comprises the following steps: pulverizing the components, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction at frequency of 3000MHz and power of 800W for 30min at 40 deg.C, extracting under hot reflux at 80 deg.C for 40min for 3 times to obtain mixed extractive solution; filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 17
The comparative example provides a composition, which comprises 16g of tortoise plastron, 20g of glabrous greenbrier rhizome, 14g of rehmannia root, 17g of raw licorice and 8g of dahurian angelica root.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a cream comprising a phase a component, a phase b component, a phase c component, and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 18
The comparative example provides a composition, which comprises 16g of tortoise plastron, 20g of glabrous greenbrier rhizome, 14g of rehmannia root, 12g of cape jasmine fruit, 13g of honeysuckle flower and 8g of dahurian angelica root.
The preparation method of the composition comprises the following steps: pulverizing carapax et Plastrum Testudinis, decocting in 160g water for 1 hr for 3 times, mixing decoctions, filtering with 100 mesh gauze, and vacuum concentrating at 70 deg.C in water bath to obtain carapax et Plastrum Testudinis extract; pulverizing the rest raw materials, sieving with 100 mesh sieve, and mixing; then adding into 1.4L ethanol water solution with volume ratio concentration of 70%, performing microwave extraction under the conditions of frequency of 3000MHz and power of 800W, extracting at 40 deg.C for 30min, extracting at 80 deg.C under hot reflux for 40min, extracting for 3 times to obtain mixed extractive solution; dissolving carapax et Plastrum Testudinis extract in the mixed extractive solution, and filtering with 100 mesh filter cloth to obtain filtrate; the filtrate was concentrated under vacuum at 50 ℃ to 100g, and then 100g of 1, 3-butanediol was added to dissolve it uniformly, to obtain the composition.
The comparative example also provides a face cream which comprises a phase a component, a phase b component, a phase c component and a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 75.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal and 5% of the composition provided by the comparative example.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest of phase c components, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
Comparative example 19
The present comparative example provides a gel comprising a phase a component, a phase B component, and a phase C component; the phase A component comprises 0.1 percent of EDTA disodium, 0.1 percent of allantoin, 0.08 percent of sodium hyaluronate, 2 percent of glyceryl polyether-26, 1 percent of glycerin, 0.6 percent of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.1 percent of carbomer and 90.42 percent of water in percentage by weight; the phase B component comprises 4% of butanediol and 0.6% of p-hydroxyacetophenone; the phase C component comprises 1% of bamboo charcoal.
The preparation method of the jelly comprises the following steps: heating and dissolving the B-phase component in a water bath kettle at 80 ℃ in advance until the component is transparent to obtain a B-phase mixture for later use; mixing the phase A components, heating and stirring in a water bath kettle at 80 ℃ until the components are dissolved uniformly, homogenizing for 3 minutes to ensure complete dissolution, and then cooling; cooling to 60 deg.C, adding the mixture of phase B, stirring to dissolve, and cooling; cooling to 45 deg.C, adding C phase component, and stirring; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh filter to obtain the jelly.
Comparative example 20
The comparative example provides a cream comprising a phase a component, a phase b component, a phase c component, a phase d component; the a-phase component comprises 1 percent of argania spinosa kernel oil, 1.2 percent of squalane, 0.4 percent of glyceryl oleate citrate, 0.1 percent of caprylic/capric triglyceride, 6 percent of cyclopentadimethylsiloxane, 1 percent of polydimethylsiloxane and 1 percent of hydrogenated lecithin in percentage by weight; the phase b component comprises 80.25% of deionized water, 0.05% of EDTA disodium, 0.1% of sodium hyaluronate, 2% of glycerol, 0.5% of trehalose, 0.75% of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and 0.2% of carbomer; the c-phase component comprises 0.15% of aminomethyl propanol, 4% of butanediol, 0.2% of methyl hydroxybenzoate and 0.1% of propyl hydroxybenzoate; the phase d component comprises 1% of bamboo charcoal.
The preparation method of the face cream comprises the following steps: heating and dissolving the phase a component in a water bath kettle at 80 ℃ in advance until the phase a component is transparent to obtain a phase a mixture for later use; adding hydroxymethyl and hydroxypropyl in the c-phase component into butanediol, and heating and dissolving in advance until the mixture is transparent to obtain a c-phase mixture for later use; dissolving EDTA disodium, sodium hyaluronate, glycerol, trehalose, an acryloyl dimethyl taurate/vinyl pyrrolidone copolymer and carbomer in the phase b component in deionized water, heating and stirring in a water bath kettle at 80 ℃ until the materials are uniformly dissolved, and homogenizing for 3 minutes to ensure complete dissolution; stirring at 1500rpm while slowly adding the phase a mixture; after the addition is finished, homogenizing and emulsifying at the speed of 5000rpm for 5-10 minutes, and then cooling; cooling to 55 deg.C, adding the mixture of phase c and the rest phase C, stirring, and cooling; cooling to 45 ℃, adding the phase d component, stirring uniformly, and continuously cooling; cooling to 37 deg.C, vacuumizing, defoaming, inspecting color, fragrance, pH, etc., and filtering with 200 mesh sieve to obtain the final product.
The compositions provided in examples 1-4 and comparative examples 8-18, and the extracts provided in comparative examples 1-7 correspond to the raw material components and content distribution shown in Table 1.
Table 1 each example and comparative example provide a table of raw material components and content distribution of the composition or extract
Performance testing
1. Evaluation of antibacterial and anti-inflammatory efficacy
The compositions provided by examples 1-4 and comparative examples 8-18 and the extracts provided by comparative examples 1-7 are respectively used as compositions to be tested to carry out antibacterial and anti-inflammatory efficacy evaluation tests, the inhibition rate of propionibacterium acnes and the inhibition rate of outer membrane vesicle release of propionibacterium acnes are used as antibacterial indexes, the inhibition rate of an inflammatory factor IL-8 is used as an anti-inflammatory index, and the specific test method is as follows:
the CCK-8 method is used for measuring the concentration of the composition without cytotoxicity, and the specific implementation method comprises the following steps: THP-1 cells were diluted with RPMI1640 medium containing 10% fetal bovine serum at 2.0X 106Inoculating the mixture with the concentration of each/mL into a 96-well plate, respectively adding the composition to be detected with the concentration of 60 mu g/mL into each 100 mu L-well plate, taking the composition to be detected as an experimental group and taking the composition not to be detected as a blank group, uniformly washing and blowing the mixture, and then placing the mixture at 37 ℃ and 5% CO2And (5) incubating for 24h in an incubator, and measuring the cell survival rate by using a CCK-8 kit method. The cell viability of the blank group is 100%, and the cell viability is more than 90%, so that the blank group is judged to be non-toxic.
The specific implementation method for detecting the inhibition rate of the composition to be detected on the propionibacterium acnes by using an absorbance method comprises the following steps: adjusting the bacteria concentration to 5.0 × 10 with culture medium6CFU/mL, adding the composition to be tested as an experimental group, taking no composition as a blank control, and culturing in a constant temperature incubator at 37 ℃ for 48h under anaerobic condition. The absorbance at 600nm was measured with an ultraviolet spectrophotometer, and the inhibition ratio of Propionibacterium acnes was calculated according to the following formula.
The BCA method is used for determining the release inhibition rate of the outer membrane vesicles of the Propionibacterium acnes, and the specific implementation method comprises the following steps: using a medium containing the composition to be tested at 37 ℃ and 5% CO2Culturing Propionibacterium acnes under the condition until logarithmic growth phase, taking the composition to be tested as an experimental group, and taking no composition as a blank control. Centrifuging at 4 deg.C and 6000g to obtain supernatant, ultrafiltering with 100KDa fiber membrane, concentrating, filtering with 0.22 μm filter, centrifuging the filtrate at 4 deg.C and 100000g for 3 hr, removing supernatant, washing with PBS for three times, and suspending in PBS to obtain outer membrane vesicle solution; the protein content of the outer membrane vesicles is measured by adopting a BCA kit method, and the outer membrane vesicle release inhibition rate is calculated according to the following formula.
The specific implementation method for measuring the inhibition rate of the inflammatory factor IL-8 comprises the following steps: THP-1 cells were plated at 5X 105Inoculating the mixture with the concentration of one/mL into a 6-pore plate, adding the composition to be detected and propionibacterium acnes, and culturing for 24 hours; measuring the content of IL-8 in cell culture supernatant by using an ELISA kit method; taking the composition to be tested and the propionibacterium acnes as experimental groups, taking the composition not to be tested and the propionibacterium acnes as blank groups, taking the composition not to be tested and the propionibacterium acnes as control groups, and calculating the IL-8 inhibition rate as an anti-inflammatory index according to the following formula.
The cell viability, Propionibacterium acnes inhibition, outer membrane vesicle release inhibition, and IL-8 inhibition for each test composition are shown in Table 2.
TABLE 2 evaluation results of antibacterial and anti-inflammatory efficacy
Note: "-" indicates negative, no effect
According to table 2, all compositions tested were non-toxic; the composition provided by the embodiments 1 to 4 has an inhibition rate of 41 to 52 percent on the reproduction of propionibacterium acnes under the synergistic effect of tortoise plastron, glabrous greenbrier rhizome, rehmannia root, raw liquoric root, gardenia and honeysuckle; the inhibition rate on the outer membrane vesicle release of the propionibacterium acnes reaches 43 to 59 percent, and the inhibition rate on an inflammatory factor IL-8 reaches 37 to 49.6 percent. Therefore, the composition provided by the embodiment of the invention has the effects of inhibiting the propagation of propionibacterium acnes, inhibiting the release of outer membrane vesicles of propionibacterium acnes and inhibiting inflammatory factors.
A certain amount of radix angelicae dahuricae is added on the basis of embodiment 4 of the invention, so that the effects of inhibiting the reproduction of propionibacterium acnes, inhibiting the release of outer membrane vesicles of propionibacterium acnes and inhibiting inflammatory factors are promoted.
Any raw material component is reduced on the basis of the formula of the composition provided by the embodiment of the invention, and the corresponding effects of inhibiting the reproduction of propionibacterium acnes, inhibiting the release of outer membrane vesicles of propionibacterium acnes and inhibiting bacteria and resisting inflammation are reduced.
The extract of tortoise plastron alone has no inhibitory effect on Propionibacterium acnes, outer membrane vesicle release and the anti-inflammatory factor IL-8. Only the glabrous greenbrier rhizome extract has no inhibition effect on the release of the outer membrane vesicles and the anti-inflammatory factor IL-8; only the rehmannia root extract has no inhibition effect on the propionibacterium acnes and the release of outer membrane vesicles; only the gardenia extract has no inhibiting effect on the anti-inflammatory factor IL-8; only the honeysuckle extract has no inhibition effect on the release of outer membrane vesicles; only the angelica dahurica extract has no inhibition effect on the anti-inflammatory factor IL-8; only the extract of tortoise plastron and the extract of smilax glabra rhizome have no inhibitory effect on the anti-inflammatory factor IL-8.
2. Evaluation of oil control effect of human body
The creams provided in the embodiment 2, the embodiment 4 and the comparative examples 8 to 18 are respectively used as the cream to be tested, and the cream provided in the comparative example 20 is used as a blank control to respectively perform the oil control effect test on the human body.
The skin oil content is tested by adopting a skin oil content test probe Sebumeter manufactured by German CK company, and the specific implementation method comprises the following steps: 280 volunteers with age between 25 and 35 and oily skin, half of men and half of women, were selected and randomly divided into 14 groups of 10 women and 10 men each. Volunteers did not use the oil control product one month prior to the test. On the first day of the test, the volunteers sit still for 30min in an environment with the temperature of 22 +/-2 ℃ and the humidity of 45 +/-5% after cleaning the skin, the volunteers keep a relaxed state, the grease data of three positions on the forehead of the volunteers are measured by the tester according to a random table, and the average value is taken. After the test on the first day, volunteers needed to apply the whole face twice in the morning and at night as required, and used the product for 28 consecutive days and returned visits on days 14 and 28.
Taking the grease data obtained by each group test, calculating the grease reduction amount of each person in each group on the 14 th day and the 28 th day, taking the average of the grease reduction amount of each group on the 14 th day as the grease reduction amount of each group on the 14 th day, taking the average of the grease reduction amount of each group on the 28 th day as the grease reduction amount of each group on the 28 th day, and listing the test results of each group in table 3.
TABLE 3 evaluation results of oil control effect
According to table 3, the creams provided in the embodiments 2 and 4 and the comparative examples 8 to 18 of the present invention have different degrees of inhibition effects on skin oil secretion, and the inhibition rate of the creams provided in the embodiments 2 and 4 of the present invention on skin oil secretion can reach more than 30% after 28 days of use, so that the effect of rapidly inhibiting skin oil secretion is achieved.
3. Evaluation of human body's efficacy in inhibiting acne
Evaluation of efficacy against acne tests were carried out with the gels provided in example 1 and comparative example 19, respectively: the acne inhibition efficacy of the traditional Chinese medicine composition of the invention is judged by quantitative analysis of facial features (pigmented spots, texture, pores, wrinkles, red areas and purple) of a VISIA facial image analyzer and professional evaluation of dermatologists. Wherein, the purpurin is porphyrin substance generated in the skin metabolic process, and the porphyrin of the facial skin is mainly derived from the propionibacterium acnes, so the detected purpurin value is in positive correlation with the number of the propionibacterium acnes; the red areas represent the underlying state of the skin, including varicose veins, inflammation and acne of the skin; the value of the red zone is positively correlated with the number of varicose veins, inflammation and acne of the skin; the pore value is mainly used for analyzing the smoothness and the expansion of the sebaceous gland, and the pore value of a common acne patient is larger.
The specific method comprises the following steps: 40 volunteers aged 25-35 and having acne evident on both sides of the face, half of each male and female, were selected, and half-face tests were performed on both sides of the face using gels provided in example 1 and comparative example 19, respectively. Volunteers avoided using other anti-acne products and anti-inflammatory drugs one month prior to the trial. On the 1 st day of the test, after cleaning the skin by using the same face cleaning product, the volunteers sit still for 30min in the environment with the temperature of 22 +/-2 ℃ and the humidity of 45 +/-5%, the faces of the volunteers are shot by using a VISIA facial image analyzer, the pigmented spots, the textures, the pores, the wrinkles, the red areas and the purple quality data of the faces of the volunteers are recorded, the absolute values are used as analysis standards, and dermatologists are asked to count the number of 5 grades of acnes such as white head acnes, black head acnes, papules, cyst nodules and pustules of the volunteers. After the test on the first day, volunteers needed to apply the whole face twice in the morning and at night as required, and used the product for 28 consecutive days and returned visits on days 14 and 28.
The test values were: the data for pigmented spots, wrinkles, lines, pores, purple, and red areas, as well as statistics for whiteheads, blackheads, papules, cystnodules, and pustules are presented in table 4.
TABLE 4 evaluation results of human anti-acne efficacy
According to table 4, after using the gel provided in example 1 for 28 days, various indexes of the face are improved, and the numerical difference of pores, purple and red areas is obvious, which indicates that the oil secretion of volunteers is reduced, the propionibacterium acnes on the face is obviously reduced, and the inflammation of the skin is relieved after using the gel containing the composition of the present invention. Therefore, the composition provided by the invention has a very remarkable inhibiting effect on acne.
According to table 4, after the gel provided in example 1 is used, the number of comedones, papules, cystic nodules and pustules on the face is obviously reduced, which shows that the composition provided in example 1 of the present invention has the effects of resisting bacteria, diminishing inflammation, reducing the secretion of skin oil and improving the influence of acne on the face.
Finally, it should be noted that the above embodiment modes are only used for illustrating the technical solutions of the present invention and are not limited, and although the present invention is described in detail with reference to the above preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.
Claims (10)
1. The composition is characterized by comprising the following raw material components: tortoise plastron, glabrous greenbrier rhizome, rehmannia root, raw liquoric root, cape jasmine fruit and honeysuckle flower.
2. The composition of claim 1, wherein the tortoise plastron is a tortoise plastron.
3. The composition of claim 1, further comprising the following raw material components: radix Angelicae Dahuricae.
4. The composition according to claim 3, which comprises the following raw material components in parts by weight: 1-20 parts of tortoise plastron, 1-25 parts of glabrous greenbrier rhizome, 1-20 parts of radix rehmanniae, 1-20 parts of raw liquorice, 1-15 parts of cape jasmine fruit, 1-15 parts of honeysuckle and 1-10 parts of dahurian angelica root;
preferably, the composition comprises the following raw material components in parts by weight: 15-20 parts of tortoise plastron, 15-20 parts of glabrous greenbrier rhizome, 8-15 parts of rehmannia root, 15-20 parts of raw liquoric root, 10-15 parts of cape jasmine fruit, 10-15 parts of honeysuckle flower and 5-9 parts of dahurian angelica root.
5. A process for the preparation of a composition according to any one of claims 1 to 4, characterized in that it comprises the following steps:
obtaining extracts of the raw material components;
mixing the extracts of the raw material components to obtain the composition.
6. The method according to claim 5, wherein the extracts from the raw material components are:
pulverizing carapax et Plastrum Testudinis, decocting, filtering, and concentrating to obtain carapax et Plastrum Testudinis extract;
pulverizing the rest raw materials, extracting with solvent, and refluxing to obtain mixed extractive solution.
7. The method according to claim 6, wherein the solvent is at least one of water, methanol, and ethanol; preferably, the extraction is microwave extraction, the frequency of the extraction is 2000-3000MHz, the power is 600-1000W, the temperature is 40-60 ℃, and the time is 20-60 min.
8. Use of a composition according to any one of claims 1 to 4 for the preparation of a cosmetic product.
9. A cosmetic comprising the composition according to any one of claims 1 to 4.
10. The cosmetic according to claim 9, wherein the composition is added in an amount ranging from 0.1% to 20% by weight relative to the total weight of the cosmetic;
preferably, the cosmetic is a gel, a cream, a mask, a lotion, an essence or a lotion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111517687.2A CN114469834A (en) | 2021-12-13 | 2021-12-13 | Composition for inhibiting acne and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111517687.2A CN114469834A (en) | 2021-12-13 | 2021-12-13 | Composition for inhibiting acne and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114469834A true CN114469834A (en) | 2022-05-13 |
Family
ID=81492610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111517687.2A Pending CN114469834A (en) | 2021-12-13 | 2021-12-13 | Composition for inhibiting acne and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114469834A (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101234164A (en) * | 2007-02-01 | 2008-08-06 | 上海中医药大学 | Pharmaceutical combination for improving skin oil-water balance and acne symptom and preparation thereof |
CN101919793A (en) * | 2009-06-15 | 2010-12-22 | 李小兵 | Chinese herbal medicine mask capable of removing acne and whitening |
CN104366169A (en) * | 2014-12-03 | 2015-02-25 | 大新县生产力促进中心 | Health-care tortoise jelly and production method thereof |
CN104382793A (en) * | 2014-11-27 | 2015-03-04 | 固镇县人民医院 | Chinese herbal medicinal ingredient cleansing milk |
CN106362091A (en) * | 2016-10-19 | 2017-02-01 | 潘清水 | Drug for treating mammary cancer |
CN106491404A (en) * | 2016-12-08 | 2017-03-15 | 广西大学 | A kind of skin care liquid and preparation method thereof |
CN110251451A (en) * | 2019-08-01 | 2019-09-20 | 刘冠宏 | Improvement or the composition and its preparation method and application for promoting cosmetic industry |
CN110478256A (en) * | 2019-09-19 | 2019-11-22 | 珠海市新高生物科技研究院有限公司 | A kind of tortoise plastron peptide silk mask formula |
CN110841000A (en) * | 2019-12-04 | 2020-02-28 | 菏泽市圣医医疗科技有限公司 | Traditional Chinese medicine mask powder capable of expelling toxin and removing acne and preparation method thereof |
CN112516044A (en) * | 2020-12-10 | 2021-03-19 | 广东诗妃化妆品有限公司 | Traditional Chinese medicine acne-removing and oil-controlling essence and preparation method thereof |
-
2021
- 2021-12-13 CN CN202111517687.2A patent/CN114469834A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101234164A (en) * | 2007-02-01 | 2008-08-06 | 上海中医药大学 | Pharmaceutical combination for improving skin oil-water balance and acne symptom and preparation thereof |
CN101919793A (en) * | 2009-06-15 | 2010-12-22 | 李小兵 | Chinese herbal medicine mask capable of removing acne and whitening |
CN104382793A (en) * | 2014-11-27 | 2015-03-04 | 固镇县人民医院 | Chinese herbal medicinal ingredient cleansing milk |
CN104366169A (en) * | 2014-12-03 | 2015-02-25 | 大新县生产力促进中心 | Health-care tortoise jelly and production method thereof |
CN106362091A (en) * | 2016-10-19 | 2017-02-01 | 潘清水 | Drug for treating mammary cancer |
CN106491404A (en) * | 2016-12-08 | 2017-03-15 | 广西大学 | A kind of skin care liquid and preparation method thereof |
CN110251451A (en) * | 2019-08-01 | 2019-09-20 | 刘冠宏 | Improvement or the composition and its preparation method and application for promoting cosmetic industry |
CN110478256A (en) * | 2019-09-19 | 2019-11-22 | 珠海市新高生物科技研究院有限公司 | A kind of tortoise plastron peptide silk mask formula |
CN110841000A (en) * | 2019-12-04 | 2020-02-28 | 菏泽市圣医医疗科技有限公司 | Traditional Chinese medicine mask powder capable of expelling toxin and removing acne and preparation method thereof |
CN112516044A (en) * | 2020-12-10 | 2021-03-19 | 广东诗妃化妆品有限公司 | Traditional Chinese medicine acne-removing and oil-controlling essence and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
国家食品药品监督管理总局: "《化妆品安全技术规范》", 31 December 2016 * |
郑虎占等: "《中药现代研究与应用(第二卷)》", 31 October 1997, 学苑出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432536B (en) | Traditional Chinese medicine composition for treating acne and preparation method thereof | |
CN104288609A (en) | Traditional Chinese medicine composition curing stomach fire flaming gingivitis and preparation method for traditional Chinese medicine composition | |
CN109288931A (en) | A kind of composition for treating infant eczema, preparation and preparation method and application | |
CN110585029A (en) | Traditional Chinese medicine herbal mask powder and preparation method and use method thereof | |
CN109549958B (en) | Composition for treating hormone-dependent dermatitis and preparation method thereof | |
CN105727110A (en) | Traditional Chinese medicine washing liquid for treating gynecological inflammation and preparing method thereof | |
CN1318052C (en) | Medicine compositions for treating acne, and its prepn. method | |
CN109260355A (en) | A kind of composition and preparation method and the application for the treatment of and improvement psoriasis | |
CN114469834A (en) | Composition for inhibiting acne and preparation method and application thereof | |
CN104383155A (en) | Chinese medicinal composition for treating constipation | |
CN101953951B (en) | Hand and feed health-care and beautifying liquid and preparation method thereof | |
CN111067856A (en) | Acne-removing traditional Chinese medicine extracting solution and facial mask and facial cream prepared from acne-removing traditional Chinese medicine extracting solution | |
CN108379377A (en) | A kind of medicinal liquor and preparation method thereof for treating snake, sting wound | |
CN104352866A (en) | Traditional Chinese medicine preparation for treating fire-toxin fluid-impairment type burns and preparation method thereof | |
CN105250815B (en) | A kind of Chinese medicine composition and preparation method thereof for treating homeliness type acne | |
CN115154521B (en) | Composition and preparation for treating psoriasis caused by external cold and internal heat and preparation method | |
CN103735699B (en) | A kind of Chinese medicine composition for the treatment of scald and preparation method thereof | |
CN115969922B (en) | External traditional Chinese medicine composition for atopic dermatitis and eczema, dehumidification paste based on external traditional Chinese medicine composition and preparation method of dehumidification paste | |
CN111494571B (en) | Traditional Chinese medicine composition for treating damp-heat blockage type gout and preparation method thereof | |
CN108704040B (en) | Traditional Chinese medicine composition and application thereof | |
CN115400190B (en) | External preparation for skin and preparation method thereof | |
CN100396302C (en) | Acne treating medicine | |
CN111388541A (en) | Traditional Chinese medicine composition for acne scars and application thereof | |
CN112826870A (en) | Composition for resisting allergy and preventing and treating eczema as well as preparation method and application thereof | |
CN116077388A (en) | Acne-removing Chinese herbal medicine composition and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220513 |